Skip to content

Clinical trials

Phase 2 Venous Thrombosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Venous Thrombosis Phase: Phase 2 Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20042
20056
20064
20072
20082
20091
20122
20133
20151
20175
20192
20205
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Terminated8
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer4
University of Utah4
Daiichi Sankyo2
Daiichi Sankyo Co., Ltd.2
GlaxoSmithKline2
Agen Biomedical1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Cardiff University1
Charite University, Berlin, Germany1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Venous Thrombosis40
Venous Thromboembolism18
Pulmonary Embolism10
Thrombosis7
Embolism and Thrombosis4
Neoplasms4
Embolism3
Atrial Fibrillation2
COVID-192
Thromboembolism2

Trials

Showing 76 to 40 of 40. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.